All residents and fellows are strongly encouraged to submit abstracts of papers to be presented at SWLC for pharmacy residents, fellows and preceptors.
The presentation format includes 15 minutes of lecture and five minutes of questions-and-answers. The presentation must be in a PowerPoint format; an LCD projector and screen will be provided. Abstracts should be submitted via
email no later than the deadline stated above. Please name your email attachment "last name.first name.abstract.docx" (i.e., albrecht.linda.abstract.docx) and send it to the Conference Director, Linda Albrecht at email@example.com.
Residents and fellows must submit their presentation in PowerPoint format no later than the deadline stated above. Changes to presentations will not be allowed after this time. Please submit the PowerPoint presentation with a title
using your name (i.e., "last name.first name.powerpoint.pptx") to the Conference Director, Linda Albrecht at firstname.lastname@example.org.
Papers are sought in the following categories for platform presentation:
This category includes reports of well-conducted original research on drug effects in humans. Examples of topics that might be covered include the following:
- Comparative efficacy and safety evaluations of two or more drug therapies;
- Exploratory studies on the clinical pharmacology and pharmacokinetics of investigational drugs;
- Analyses of the incidence and severity of adverse drug reactions;
- Bioavailability studies in human subjects; and
- Comparative evaluations of the clinical usefulness of various laboratory methods.
COMMAND PERFORMANCE REPORTS
This category includes clinical research reports that have been presented elsewhere. Submissions must be reports of original research in clinical or laboratory research.
These submissions must report completed original research. Included in this category are evaluative studies of new roles or services in institutional pharmacy practice.
These are contributions reporting new, improved, or innovative roles or services in pharmacy practice that have not been evaluated formally, but are of such importance that they should be
brought to the attention of other practitioners. Also, reports of clinical cases that do not meet the criteria for evaluative studies fall into this category. Examples of the latter include reports of unusual drug reactions
involving only one or a few patients or unique uses of drugs in a limited number of patients when the drugs involved are important therapeutic agents.
These reports present uncompleted evaluative studies (or clinical/laboratory research) that are currently in progress and will most likely still be in progress at the time of the meeting.
Research-in-progress reports allow investigators to bring their projects to the attention of colleagues earlier than would otherwise be possible. In addition, a forum is provided for investigators to benefit from peer review
at a stage when appropriate modifications can still be made in study methods, data collection and analysis or interpretation of results.
CASE STUDIES IN HOSPITAL PHARMACY MANAGEMENT
These management case studies are intended to take the audience through an analysis of the sequential steps or processes involved in resolving a particular problem,
implementing a change, developing and implementing a new system or program, planning and organizing an administrative function, or some other example of applied institutional pharmacy management. The primary objective is not
simply to offer a forum for the presenter to tell the audience what was done, but rather to join the audience in a critical analysis of the case.
One component of each of the specialty residency standards for accreditation by ASHP is an investigational or research project. There are also a number of Clinical Sciences Fellowship programs
in the Southwest, and these are especially oriented toward research. In some cases laboratory research is conducted, and the SWLC would encourage persons engaged in this type of scholarly work to present reports on completed
projects or in the category, “Research-in-Progress.” (ASHP does not include “Laboratory Research” as one of its categories.)